Osmolar-gap in the setting of metformin-associated lactic acidosis
<h3>Rationale</h3><p dir="ltr">Metformin-associated lactic acidosis (MALA) is a rare adverse effect that has significant morbidity and mortality. MALA is a high anion gap (AG), nonosmolar acidosis. Associated osmolar-gap (OG) is rarely reported, so finding an OG may make...
Saved in:
| Main Author: | Mohamed Nabil Elshafei (9960500) (author) |
|---|---|
| Other Authors: | Mohammed Alamin (20375244) (author), Mouhand F.H. Mohamed (16932579) (author) |
| Published: |
2020
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impact of metformin therapy for gestational diabetes on fetal growth in women with risk factors for fetal growth restriction- a registry-based study from Qatar
by: Komal Rafique (17075074)
Published: (2023) -
Impact of metformin treatment on cobalamin status in persons with type 2 diabetes
by: Sundus Fituri (17945294)
Published: (2023) -
Metformin: Is it a drug for all reasons and diseases?
by: Chris R. Triggle (4278688)
Published: (2022) -
Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer
by: Samson Samuel (6828956)
Published: (2019) -
Neratinib and metformin: A novel therapeutic approach against HER2-Positive Breast Cancer
by: Kheraldine, Hadeel
Published: (2025)